Cynapsus Therapeutics Cash Flow - Annual (NASDAQ:CYNA)

Add to My Stocks
$40.48 $0 (0%) CYNA stock closing price Oct 21, 2016 (Closing)

The financial analysis of CYNA requires an investor to check the cash flows for Cynapsus Therapeutics. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Cynapsus Therapeutics profits one has to check the income statement and for Cynapsus Therapeutics debt one has to check the balance sheet. The cash flow statement is essetial while conducting the Cynapsus Therapeutics cash flow analysis and can be used to measure the operating performance of Cynapsus Therapeutics compared to various industry peers like SIGA stock and CASI stock. The cash from operating activities for Cynapsus Therapeutics is $ 2015, which saw a decrease from previous year.

View details of Cynapsus Therapeutics cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2015201420132012
Net Income Cash Flow
-21.52M-9.8M-4.3M-3.06M
Depreciation Depletion Amortization Cash-Flow----
Net Increase (Decrease) in Assets Liabilities1.22M---
Cash From (used in) Discontinued Operations----
Other Adjustments Net-5.06M--0.43M1.2M
Net Cash from (used by) Operating Activities
-25.23M-9.05M-4.06M-1.33M
Increase (Decrease) in Prop Plant And Equipment-0.33M-0.23M-0.01M-
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments----
Other Cash Inflow (Outflow) from Investment Activities----
Net Cash from (used by) Investment Activities
-0.33M-0.23M-0.01M-
Issuance (Purchase) of Equity Shares91.58M24.35M7.1M-
Issuance (Repayment) of Debt Securities---0.21M-
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities-7.49M-1.95M-0.64M-
Net Cash from (used by) Financing Activities
84.08M22.39M6.24M1.09M
Effect of Exchange Rate Changes on Cash10.02M---
Net Change in Cash & Cash Equivalents
68.53M13.73M2.17M-0.24M
Cash & Equivalents at Beginning of Year13.67M2.07M--
Cash & Equivalents at Year End82.2M15.81M2.22M-
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Cynapsus Therapeutics stock price history and Cynapsus Therapeutics stock comparison chart inevitably reflect its cash flow situation.

  • Cynapsus Therapeutics has cash of $82.2M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Cynapsus Therapeutics stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Cynapsus Therapeutics lost $-25.23M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.33M for CYNA in last 2015 report.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Cynapsus Therapeutics earned $84.08M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.